@diabetologiajnl.bsky.social
We publish high-quality, cutting edge articles on all aspects of diabetes, from basic science through translational work to clinical research
@diabetologiajnl.bsky.socialUp front & free to read in our Oct issue #editorspicks: GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single‑blinded, placebo‑controlled, crossover study link.springer.com/article/10.1...
@diabetologiajnl.bsky.socialUp front & free to read in our Oct issue #editorspicks: Delayed maturation of the milk microbiome in women with type 1 diabetes link.springer.com/article/10.1...
@easdnews.bsky.socialReposted by @diabetologiajnl.bsky.social📣 One week left until the next EASD Early Career Academy webinar!
Join Prof. Fredrik Bäckhed for the next EASD Early Career Academy #webinar on the gut microbiota in cardiometabolic disease, with a focus on #diabetes.
📅 15 Oct 2026 | 🕛 16:00 CEST
🔗👉 Register now: us06web.zoom.us/webinar/regi...
@diabetologiajnl.bsky.socialNew study shows empagliflozin and dapagliflozin have comparable risk of liver-related complications, with only marginally greater improvement in fatty liver with empagliflozin, in adults with type 2 diabetes and MASLD. #MASLD #SGLT2i #T2D #LiverHealth link.springer.com/article/10.1...
@hospitaldelmar.bsky.socialReposted by @diabetologiajnl.bsky.social🧬La nova eina GPCRvp, de @researchmar.bsky.social i @institutcochin.bsky.social, millora la predicció de l'impacte del #GLP1, relacionat amb la diabetis i l'obesitat.
👩🔬Amb la Dra. Jana Selent i Marta López Balastegui.
📝Publicat a @diabetologiajnl.bsky.social.
🔗 www.hospitaldelmar.cat/ca/noticies/...
@diabetologiajnl.bsky.socialUp front & free to read in our Oct issue #editorspicks: A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes link.springer.com/article/10.1...
@easdnews.bsky.socialReposted by @diabetologiajnl.bsky.social👧 👦 Why is it so important for children with a genetic risk for #T2D to keep a healthy weight?
👉 The paper chosen by Dana Dabelea for this Gamechangers episode investigated the association between #GRS, #BMI and youth-onset #T2D.
📺 Watch here: easd-elearning.eu/episode/381/...
@diabetologiajnl.bsky.socialLargest study to date on glucose-lowering agents in early pregnancy (n=19,092). Overall reassuring for malformations, but a possible cardiac signal with GLP-1 RA & sulfonylureas to watch. #diabetes #pregnancy #maternalhealth #GLP1 link.springer.com/article/10.1...
@diabetologiajnl.bsky.socialUp front & free to read in our Oct issue #editorspicks: Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction‑based approaches link.springer.com/article/10.1...
@diabetologiajnl.bsky.socialA new #ExpertForum review reshapes our view of #InsulinResistance! Moving past uniform definitions, it presents IR as a dynamic, tissue-specific biological phenotype driven by metabolic stress & adaptation link.springer.com/article/10.1... 🔓 @adapubs.bsky.social
@easdnews.bsky.socialReposted by @diabetologiajnl.bsky.social@easdnews.bsky.socialReposted by @diabetologiajnl.bsky.social🧠Meet Dr Kálmán Benedikt Bódis, #EFSD & #Lilly Young Investigator Research Award recipient. His project explores how restoring blood flow affects wound microbiome in #diabeticfoot ulcers for more personalised treatment.
📖 link.springer.com/article/10.1...
Supported by Lilly Diabetes International.
@diabetologiajnl.bsky.socialGAD alum treatment delayed onset of stage 3 type 1 diabetes in autoantibody-positive children with HLA-DR3-DQ2. The findings support treatment based on genetic risk and highlight the need for further studies of GAD alum #T1D #Diabetes link.springer.com/article/10.1... 🔓
@diabetologiajnl.bsky.socialUp front & free to read in our Oct issue #editorspicks: Dementia in type 2 diabetes: risk factors, disease processes and opportunities for prevention across the lifespan link.springer.com/article/10.1...
@diabetologiajnl.bsky.socialAlthough physical activity at any time of day improves health, some evidence suggests potential benefits of afternoon/evening activity for glycaemic and lipid-related outcomes in individuals at risk of type 2 diabetes #ExerciseTiming #MetabolicHealth link.springer.com/article/10.1... 🔓
@diabetologiajnl.bsky.socialMost autoimmune diabetes develops in adulthood, but modifiable risk factors are poorly understood. Review identifies obesity & smoking as the most consistent risk factors & highlights key research gaps. #LADA #Type1Diabetes link.springer.com/article/10.1... 🔓
@diabetologiajnl.bsky.socialSeeking new triggers for #GLP-1 secretion? Sphinganine emerged as the strongest predictor of postprandial GLP-1 responses in humans - it stimulated GLP-1 release in vitro and reduced weight gain in mice #DiabetesResearch link.springer.com/article/10.1... 🔓
@metabologiajnl.bsky.socialReposted by @diabetologiajnl.bsky.socialMetabologia wants your research papers on the #metabolic aspects of #diabetes, #obesity #CVD and #renal and #hepatic disease #comorbidity #nutrition #exercise #psychosocial #healtheconomics #healthtechnology – submit now! metabologia.org #EASD2026
@diabetologiajnl.bsky.socialSmart insulin pen systems (SPS) paired with CGM offer dose calculation, IOB tracking & adherence support. They bridge the gap between MDI & AID #T1D #Insulin #DiabetesResearch link.springer.com/article/10.1... 🔓️
@diabetologiajnl.bsky.socialIn our 2026 special issue: Is #MASLD an independent risk factor for micro- and macrovascular complications of #diabetes? A critical reappraisal and future directions link.springer.com/article/10.1...
